等待開盤 04-02 09:30:00 美东时间
+0.450
+0.25%
(来源:药时代) 预计阅读时间:3分钟 2026年3月31日,Biogen宣布以56亿美元收购Apellis Pharmaceuticals(Nasdaq:A...
04-01 11:52
百健公司(BIIB.US)已同意以56亿美元收购Apellis Pharmaceuticals(APLS.US),此举将扩大其在免疫学和罕见病领域的治疗版图,成为该公司历史上规模最大的收购交易之一。
03-31 21:08
Eye drug developer Apellis Pharmaceuticals (APLS) added ~137% in the premarket on Tuesday after the company agreed to be acquired by Biogen (BIIB) for $41 per share in a deal worth $5.6B. The acquisit...
03-31 19:15
The US FDA has approved a high-dose regimen of Biogen's (BIIB) spinal muscular atrophy treatment Spinraza (nusinersen) consisting of 50 mg/5 mL and 28 mg/5 mL doses. Biogen said that the new regimen a...
03-31 00:07
Alteogen on Wednesday announced an exclusive license agreement with Biogen (BIIB) to develop subcutaneously delivered biologics leveraging the South Korean pharma's Hybrozyme platform technology. At t...
03-26 00:20
CAMP4 Therapeutics announced the appointment of Michael MacLean to its Board of Directors. With over 35 years of financial and operational leadership in biotechnology, MacLean brings extensive experience in growing innovative biotech companies. His expertise will support CAMP4 as it advances its CMP-002 program toward a Phase 1/2 clinical trial for SYNGAP1-related disorder, for which there are currently no approved treatments. MacLean previously ...
03-24 11:00
联邦快递涨8.94%;Leonardo DRS涨2.48%;Solstice Advanced Materials, Inc.涨2.40%
03-20 06:10